PerkinElmer has announced the launch of an in vivo imaging device for use in the analysis of animals used in medical research.
The Multispecies Imaging Module is designed for use with the company's own Fluorescence Molecular Tomography In Vivo Imaging Systems and allows users to create 3D datasets of animal models.
Using non-invasive fluorescence molecular tomography, the system lets researchers generate images of small animals such as mice, as well as larger species including rats and guinea pigs.
This data can be used in the study of conditions such as cancer, autoimmune disorders and rheumatoid arthritis, allowing potential failed drug candidates to be filtered out at the earliest possible stage.
Achim von Leoprechting, vice-president and general manager for imaging and detection technologies in the company's bio-discovery business unit, said: "PerkinElmer is delighted to offer preclinical researchers expanded imaging and dataset-building capabilities for understanding disease."
Last week, the firm announced plans to expand its epigenetic detection reagents portfolio, responding to the increasing importance of this area of research.